KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesInvestment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax RateTax Rate
Others
Ratios

Sabra Health Care REIT (SBRA) EBITDA (2016 - 2026)

Sabra Health Care REIT has reported EBITDA over the past 11 years, most recently at $67.8 million for Q1 2026.

  • For Q1 2026, EBITDA changed 0.34% year-over-year to $67.8 million; the TTM value through Mar 2026 reached $266.1 million, up 4.24%, while the annual FY2025 figure was $265.9 million, 9.25% up from the prior year.
  • EBITDA for Q1 2026 was $67.8 million at Sabra Health Care REIT, up from $54.9 million in the prior quarter.
  • Over five years, EBITDA peaked at $92.8 million in Q2 2025 and troughed at -$18.0 million in Q3 2022.
  • A 5-year average of $49.2 million and a median of $53.6 million in 2024 define the central range for EBITDA.
  • Biggest five-year swings in EBITDA: crashed 146.79% in 2022 and later surged 315.46% in 2024.
  • Year by year, EBITDA stood at $31.4 million in 2022, then surged by 47.73% to $46.4 million in 2023, then soared by 62.31% to $75.3 million in 2024, then fell by 27.01% to $54.9 million in 2025, then rose by 23.46% to $67.8 million in 2026.
  • Business Quant data shows EBITDA for SBRA at $67.8 million in Q1 2026, $54.9 million in Q4 2025, and $50.6 million in Q3 2025.